NCT05714345 2026-03-02
EXPAND
Allogene Therapeutics
Phase 2 Terminated
Clinical Trials
6 trialsNCT03990961 2026-02-20
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
University of Chicago
Phase 2 Terminated
NCT03779113 2026-02-18
An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma
Hutchmed
Phase 1 Terminated
NCT04716153 2026-01-20
RE-NEZ-SENS
University Hospital, Montpellier
Phase NA Terminated
NCT04940468 2026-01-14
High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology
University of Colorado, Denver
Phase NA Terminated
NCT03283423 2026-01-09
Image-guided Lymphadanectomy in AMIGO
Brigham and Women's Hospital
Phase NA Terminated